These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22314936)

  • 21. The LIFTMOR-M (Lifting Intervention For Training Muscle and Osteoporosis Rehabilitation for Men) trial: protocol for a semirandomised controlled trial of supervised targeted exercise to reduce risk of osteoporotic fracture in older men with low bone mass.
    Harding AT; Weeks BK; Watson SL; Beck BR
    BMJ Open; 2017 Jun; 7(6):e014951. PubMed ID: 28611110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.
    Cheung E; Cheung CL; Kung AW; Tan KC
    Osteoporos Int; 2014 Mar; 25(3):1017-23. PubMed ID: 24196720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Rothmann MJ; Möller S; Holmberg T; Højberg M; Gram J; Bech M; Brixen K; Hermann AP; Glüer CC; Barkmann R; Rubin KH
    Osteoporos Int; 2017 Dec; 28(12):3389-3399. PubMed ID: 28875257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.
    Kingkaew P; Maleewong U; Ngarmukos C; Teerawattananon Y
    Value Health; 2012; 15(1 Suppl):S20-8. PubMed ID: 22265062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
    Shetty S; John B; Mohan S; Paul TV
    Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of screening to prevent osteoporotic fractures: a qualitative study with older women.
    Emmett CL; Redmond NM; Peters TJ; Clarke S; Shepstone L; Lenaghan E; Shaw AR
    Fam Pract; 2012 Apr; 29(2):235-42. PubMed ID: 21908537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT.
    Barker KL; Newman M; Stallard N; Leal J; Minns Lowe C; Javaid MK; Noufaily A; Adhikari A; Hughes T; Smith DJ; Gandhi V; Cooper C; Lamb SE
    Health Technol Assess; 2019 Aug; 23(44):1-318. PubMed ID: 31456562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention of osteoporosis: mass screening scenario or prescreening with questionnaires? An economic perspective.
    Richy F; Ethgen O; Bruyere O; Mawet A; Reginster JY
    J Bone Miner Res; 2004 Dec; 19(12):1955-60. PubMed ID: 15537437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial - a pragmatic multicentre randomised controlled trial evaluating the clinical effectiveness and cost-effectiveness of surgical compared with non-surgical treatment for proximal fracture of the humerus in adults.
    Handoll H; Brealey S; Rangan A; Keding A; Corbacho B; Jefferson L; Chuang LH; Goodchild L; Hewitt C; Torgerson D
    Health Technol Assess; 2015 Mar; 19(24):1-280. PubMed ID: 25822598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY
    Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.
    Borgström F; Ström O; Kleman M; McCloskey E; Johansson H; Odén A; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):955-65. PubMed ID: 20532482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial).
    Cockayne S; Rodgers S; Green L; Fairhurst C; Adamson J; Scantlebury A; Corbacho B; Hewitt CE; Hicks K; Hull R; Keenan AM; Lamb SE; McIntosh C; Menz HB; Redmond A; Richardson Z; Vernon W; Watson J; Torgerson DJ
    Health Technol Assess; 2017 Apr; 21(24):1-198. PubMed ID: 28621259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk.
    Barr RJ; Stewart A; Torgerson DJ; Reid DM
    Osteoporos Int; 2010 Apr; 21(4):561-8. PubMed ID: 19565176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX.
    Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey EV; Kanis JA
    Osteoporos Int; 2010 Mar; 21(3):495-505. PubMed ID: 19565175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M; Davis S; Lloyd-Jones M; Beverley C
    Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
    Meunier PJ; Roux C; Ortolani S; Diaz-Curiel M; Compston J; Marquis P; Cormier C; Isaia G; Badurski J; Wark JD; Collette J; Reginster JY
    Osteoporos Int; 2009 Oct; 20(10):1663-73. PubMed ID: 19153678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Si L; Winzenberg TM; Jiang Q; Palmer AJ
    Osteoporos Int; 2015 May; 26(5):1477-89. PubMed ID: 25567776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.
    Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2010 Feb; 21(2):339-49. PubMed ID: 19513577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.